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ABSTRACT 1 
Objectives: To determine the potential role of cardiovascular autonomic dysfunction 2 
in the development of renal complications in young people with type 1 diabetes 3 
(T1D). 4 
Methods: In this prospective study, 199 children and adolescents recruited to the 5 
Oxford Regional Prospective Study underwent assessment of autonomic function ~5 6 
years after diagnosis, and were subsequently followed with longitudinal assessments 7 
of HbA1c and urine albumin-creatinine ratio (ACR) over 8.6 ± 3.4 years. Autonomic 8 
function was assessed with 4 standardized tests of cardiovascular reflexes: heart 9 
rate (HR) response to (i) Valsalva Maneuver, (ii) deep breathing, and (iii) standing, 10 
and (iv) blood pressure (BP) response to standing. Linear mixed models were used 11 
to assess the association between autonomic parameters and future changes in 12 
ACR.  13 
Results: Independent of HbA1c, each SD increase in HR response to Valsalva 14 
Maneuver predicted an ACR increase of 2.16% [95% CI: 0.08; 4.28] per year 15 
(p=0.04), while each SD increase in diastolic BP response to standing predicted an 16 
ACR increase of 2.55% [95% CI: 0.37; 4.77] per year (p=0.02). The effect of HR 17 
response to standing on ACR reached borderline significance (-2.07% [95% CI: -18 
4.11; 0.01] per year per SD increase, p=0.051). 19 
Conclusions: In this cohort of young people with T1D, enhanced cardiovascular 20 
reflexes at baseline predicted future increases in ACR. These results support a 21 
potential role for autonomic dysfunction in the pathogenesis of diabetic nephropathy. 22 
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INTRODUCTION 1 
Subclinical autonomic neuropathy is a common complication of type 1 diabetes 2 
(T1D), which has been observed as early as 2 years after T1D diagnosis [1]. A 3 
recent systematic review has reported a variable prevalence of abnormal 4 
cardiovascular nerve function tests in young people with T1D, ranging from 16 to 5 
75% [2].  6 
Autonomic dysfunction has been proposed as a pathogenic mechanism which may 7 
underlie future renal and cardiovascular complications in the general population and 8 
in people with T1D [3–5]. Cross-sectional studies indicate that impaired autonomic 9 
function, as documented by conventional cardiovascular reflex tests or spectral 10 
analysis of resting electrocardiograms, is associated with renal complications of T1D 11 
[6,7]. However, human clinical data are limited and the best evidence for causality 12 
comes from preclinical models, whereby renal denervation increased albumin 13 
excretion rates (AER) in streptozotocin-induced diabetic rats [8].  14 
Extensive evidence indicates that increases in urinary albumin excretion, even within 15 
the normal range, predict renal and cardiovascular disease (CVD) risk in the normal 16 
population as well as in people with T1D [9,10]. Increased albumin-creatinine ratio 17 
(ACR) within the normal range has been found to predict 85% of adolescent patients 18 
who will subsequently develop microalbuminuria as young adults [11]. In addition, in 19 
adolescents with T1D, an ACR in the top 30% of the normal range is associated with 20 
early signs of cardiovascular disease, such as increased arterial stiffness and aortic 21 
intima-media thickness [12,13].  22 
Longitudinal data exploring the relationship between autonomic dysfunction and 23 
subsequent changes in urinary albumin excretion could be valuable in determining 24 
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the contribution of autonomic dysfunction to the pathogenesis of renal and 1 
cardiovascular complications of T1D. However, to date only two studies have been 2 
reported [14,15] and they showed that smaller resting pupil diameter [15] and 3 
reduced heart rate response to deep breathing [14] at baseline increased the risk of 4 
developing micro- or macroalbuminuria during follow-up. One of these studies 5 
involved an adolescent population, but it was limited by a high rate of loss of subjects 6 
during follow-up (41% of the original cohort) [2,15]. The other study was based on an 7 
adult population with T1D, with a 13-year duration of diabetes, and a high prevalence 8 
(50%) of micro- or macroalbuminuria at baseline [14].  9 
The aim of the present study was to assess the association between cardiovascular 10 
autonomic dysfunction and subsequent changes in urinary albumin excretion in a 11 
cohort of young people with childhood-onset T1D recruited and followed in the 12 
Oxford Prospective Regional Study (ORPS).  13 
 14 
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MATERIALS AND METHODS 1 
Recruitment and follow-up 2 
ORPS is a large, well-characterized, population-based inception cohort of childhood-3 
onset T1D patients, recruited at diagnosis and followed thereafter with annual 4 
standardized assessments [16,17]. The study methods have been reported in detail 5 
elsewhere [11,16–18]. Briefly, children and adolescents with T1D were recruited 6 
during a 10-year period, between 1986 and 1996, from the St. Bartholomew's Oxford 7 
diabetes register. T1D patients had to be less than 16 years old at the time of 8 
diagnosis, and were approached within 3 months of diagnosis. Ninety-one percent 9 
(n=527) of eligible children were recruited at a mean age of 8.8 years and were 10 
followed annually thereafter. The overall dropout rate for the ORPS cohort has been 11 
9.6%. The study received ethical approval from district ethics committees. Written 12 
consent was obtained from parents, and verbal assent was obtained from children.  13 
 14 
213 participants agreed to have a one-off autonomic assessment approximately 5 15 
years after T1D diagnosis. Of these, 14 participants were excluded due to 16 
incomplete data, and the remaining 199 represent the study population for the 17 
present study.  18 
Annual assessments 19 
Annual assessments included anthropometric measurements (height, weight, BMI), 20 
collection of blood samples for the measurement of HbA1c and collection of urine 21 
samples for the assessment of ACR. Due to the variability in urine ACR, 3 22 
consecutive first-void early morning urine samples were collected from each 23 
participant, and the geometric mean of the ACR measurements was calculated. All 24 
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biochemical measurements were performed centrally. HbA1c was measured initially 1 
using electrophoresis and then, after 1992, using high performance liquid 2 
chromatography. Albumin and creatinine were measured using double antibody 3 
enzyme linked immunosorbent assay (ELISA) and the modified Jaffe method 4 
respectively. The relationship between urine ACR and AER has been characterized 5 
in this cohort [18]. As in previous studies [11,16,17,19], microalbuminuria was 6 
defined as an ACR of 3.5-35mg/mmol in males and 4.0-47mg/mmol in females. 7 
Macroalbuminuria referred to an ACR of >35mg/mmol in males and 47mg/mmol in 8 
females. The ACR was not normally distributed and was log10 transformed. 9 
Autonomic assessment 10 
The autonomic assessment comprised 4 standard tests of cardiovascular reflexes, 11 
performed following the methods described by Ewing and colleagues [20]. These 12 
tests assessed the (i) heart rate (HR) response to Valsalva Maneuver, (ii) HR 13 
response to deep breathing, (iii) HR response to standing, and (iv) blood pressure 14 
(BP) response to standing, and were performed in this order. Autonomic parameters 15 
summarizing the result of each cardiovascular reflex test were calculated from raw 16 
measurements, as follows: 17 
(i) HR response to Valsalva Maneuver: Longest RR after Valsalva Maneuver ÷ 18 
Shortest RR before Valsalva Maneuver;  19 
(ii) HR response to deep breathing: 60/Shortest RR – 60/Longest RR, with RR 20 
interval in seconds; 21 
(iii) HR response to standing: Longest RR ÷ Shortest RR; 22 
(iv) BP response to standing: Systolic BP (SBP) response= SBP standing - SBP 23 
lying; Diastolic BP (DBP) response= DBP standing - DBP lying 24 
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All ratios were log10 transformed for further analysis to maintain symmetry along a 1 
linear scale. 2 
 3 
Statistical analysis 4 
Linear mixed models (random coefficient models) were used to maximize the 5 
statistical power of the repeated outcome measurements made over time in the 6 
longitudinal study design [21], while adequately accounting for the correlation 7 
between measurements [22,23].  8 
A linear mixed model was created including time (since autonomic assessment) as a 9 
first level predictor, and the following covariates: sex, duration of diabetes, age at 10 
autonomic assessment, mean HbA1c during duration of follow-up (after autonomic 11 
assessment). An unstructured covariance was used and parameter estimation 12 
performed using the maximum likelihood method. To determine if random effects, i.e. 13 
unexplained variation, in baseline ACR and its rate of change over time needed to be 14 
modeled, the -2 Log Likelihood statistic was compared between alternative models 15 
using the χ2 test [24]. The best fit was obtained with both random intercepts and 16 
random slopes included, yielding an Akaike’s Information Criterion (AIC) of 598.39. 17 
Separate models were then created, each including one of the five autonomic 18 
parameters measured, unless otherwise stated. Autonomic parameters were 19 
transformed into Z-scores before inclusion in the models, to facilitate comparison of 20 
their relative effect sizes. Z-scores were calculated using the formula (x-µx)/SDx, 21 
where x refers to the autonomic parameter under consideration, and µ and SD refer 22 
to the mean and standard deviation respectively. Only ACR and HbA1c 23 
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measurements made after autonomic assessment were used, as it is the period after 1 
autonomic assessment which is the study period under consideration. 2 
SPSS Version 23 (IBM Corp., Armonk, NY) was used for all analyses, and a p-value 3 
of 0.05 used as the cut-off for statistical significance. Normality was determined 4 
graphically. All values are given as mean ± SD unless otherwise specified. 5 
6 
8 
 
RESULTS 1 
The clinical and autonomic characteristics of the 199 study participants are shown in 2 
Table 1. These 199 participants did not differ from the remainder of the ORPS cohort 3 
in terms of sex distribution (female: 47.2% vs 44.2%), age at diagnosis (median 4 
[interquartile range]: 9.25 [5.94-1180] vs 9.73 [5.01-12.42] years), mean HbA1c (9.69 5 
± 1.38 vs 9.89 ± 1.58% or 82.4 ± 15.1 vs 84.6 ± 17.3 mmol/mol), mean log10ACR 6 
(0.023 ± 0.282 vs 0.031 ± 0.326). 7 
 8 
Longitudinal profile of Urine ACR 9 
At the time of autonomic function assessment, only 14 participants had ACR 10 
measurements in the micro- or macroalbuminuric range. During follow-up, 57 11 
participants showed ACR in the micro- or macroalbuminuric range, with 8 developing 12 
macroalbuminuria. Using linear mixed models with time as the only covariate, the 13 
longitudinal profile of urine ACR was explored. As shown in Figure 1, participants 14 
who developed micro- or macroalbuminuria demonstrated an increase in ACR with 15 
time (9.94% [95% CI: 3.21 – 17.11] per year, p=0.004), while participants who 16 
remained normoalbuminuric demonstrated a small decrease in ACR with time (-17 
2.28% [95% CI: -3.24 – -1.32] per year, p<0.001).  18 
Effect of Cardiovascular Reflexes on Urine ACR 19 
The value of cardiovascular reflex tests performed at baseline in predicting 20 
subsequent changes in urine ACR was tested using linear mixed models, adjusting 21 
for sex, duration of diabetes, age of assessment and mean HbA1c during follow-up.  22 
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Of the examined autonomic parameters, 2 displayed a significant relationship with 1 
the rate of change of ACR: HR response to Valsalva Maneuver (2.16% [95% CI: 2 
0.08; 4.28] per year per SD increase, p=0.041), and DBP response to standing 3 
(2.55% [95% CI: 0.37; 4.77] per year per SD increase, p=0.022) (Figure 2). The 4 
effect of HR response to standing reached borderline significance (-2.07% [95% CI: -5 
4.11; 0.01] per year per SD increase, p=0.051). The HR response to standing was 6 
not determined by the maximum heart rate response (p=0.75), but instead by the 7 
longest RR interval (p<0.001), indicating persistence of the initial cardio-acceleratory 8 
response. In these models, the effect sizes of autonomic parameters were of 9 
comparable magnitude to that of HbA1c, i.e. 5.55-5.94% per year per SD increase 10 
(p<0.001) or 3.86-4.13% per year per % increase. 11 
To test if the predictive effect of HR response to Valsalva Maneuver, DBP response 12 
to standing and HR response to standing were independent and thus additive, these 13 
autonomic parameters were introduced into the same linear mixed model together 14 
with the aforementioned covariates. HR response to standing displayed a significant 15 
relationship with the rate of change of urine ACR (-2.65% [95% CI: -4.85 – -0.040] 16 
per year per SD increase, p=0.022). However, HR response to Valsalva Maneuver 17 
was of borderline significance (2.30% [95% CI: -0.003 – 4.66] per year per SD 18 
increase, p=0.050), and there was no significant effect of DBP response to standing 19 
(1.23% [95% CI: -1.05 – 3.56] per year per SD increase, p=0.29).  20 
On bivariate analysis of the 3 autonomic parameters, the only significant correlation 21 
was between HR response to Valsalva Maneuver and DBP response to standing 22 
(r=0.216, p=0.004). To assess the influence of colinearity between HR response to 23 
Valsalva Maneuver and DBP response to standing on these results, the latter was 24 
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removed from the model. This resulted in the effect of HR response to Valsalva 1 
Maneuver reaching statistical significance (2.16% [95% CI: 0.12 – 4.24] per year per 2 
SD increase, p=0.038), and a largely unchanged effect of HR response to standing (-3 
2.40% [95% CI: -4.43 – -0.33] per year per SD increase, p=0.023) (Table 2).  4 
Similarly, when HR response to Valsalva Maneuver was removed from the model, 5 
the effect size of HR response to standing remained similar (-2.28% [95% CI: -4.50 – 6 
-0.015] per year per SD increase, p=0.049), while the effect size of DBP response to 7 
standing increased but still did not reach significance (1.66% [95% CI: -0.59 – 3.96] 8 
per year per SD increase, p=0.15). 9 
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DISCUSSION 1 
In this study, we report an association between early signs of cardiovascular 2 
autonomic dysfunction and increasing urine ACR in young people with childhood-3 
onset T1D. To our knowledge, this is the first such report in a young population with 4 
T1D predominantly normoalbuminuric at baseline.  5 
The longitudinal profile of urine ACR in this cohort is in line with earlier observations 6 
suggesting that only certain patients with T1D are susceptible to developing diabetic 7 
nephropathy [17,25]. ACR only increased longitudinally in the subpopulation of 8 
participants who eventually developed micro- or macroalbuminuria, and instead was 9 
stable or even decreased in participants who remained normoalbuminuric during 10 
follow up.  11 
In this study, we showed that autonomic parameters derived from standard tests of 12 
cardiovascular reflexes performed at baseline, were predictive of subsequent 13 
increases in ACR with time, independent of HbA1c. More specifically, longitudinal 14 
increases in ACR were predicted by an enhanced HR response to the Valsalva 15 
Maneuver as well as an enhanced DBP response to standing. There was also an 16 
association with HR response to standing that reached borderline significance. Thus, 17 
early cardiovascular autonomic dysfunction in the form of enhanced cardiovascular 18 
reflexes is associated with subsequent longitudinal increases in ACR. 19 
This pattern of autonomic dysfunction is consistent with enhanced sympathetic tone 20 
relative to parasympathetic or vagal tone [26,27], as has been also observed in T1D 21 
populations using spectral analysis of resting electrocardiograms [28]. 22 
12 
 
Relative sympathetic overactivity may represent an important mechanism by which 1 
renal injury occurs. In the large population-based Atherosclerosis Risk in 2 
Communities study, a relative increase in sympathetic tone as identified by spectral 3 
analysis of electrocardiograms, was associated with increased risk of chronic kidney 4 
disease-related hospitalizations, even after adjusting for diabetes status, fasting 5 
plasma glucose and insulin, in addition to other covariates [29]. In addition, other 6 
clinical phenomena associated with renal injury in populations with and without 7 
diabetes may have their basis in relative sympathetic overactivity. Examples include 8 
the non-dipper phenomenon [30,31], as well as orthostatic hypertension [32,33].  9 
A potential study limitation might be the methodology used to assess autonomic 10 
dysfunction. Although the selected tests of cardiovascular reflexes are well-validated 11 
and clinically applicable [34–36], they reflect autonomic function only at a certain 12 
time of the day, instead of a 24-hour assessment of autonomic function. Recent 13 
studies have mainly used time and frequency domain measures of heart rate 14 
variability to characterize cardiac autonomic function in patients with diabetes, and 15 
these measures are thought to be more reproducible and better tolerated by patients. 16 
However, some previous studies reported a good correlation between results of 17 
cardiovascular reflexes and time and frequency measures [37], and similar 18 
associations with microalbuminuria [38]. An additional limitation of the present study 19 
could be related to the the inclusion of autonomic parameters as interval variables in 20 
the multivariable analyses, thus  providing little guidance as to which values of 21 
autonomic parameters are considered abnormal and might warrant greater clinical 22 
attention. In addition, it needs to be acknowledged that glycemic control in this 23 
historical population, mainly on twice-daily insulin regimen, was well-above the 24 
13 
 
recommended values for adolescents and this might have influenced the study 1 
findings, and limits the applicability of the study findings to populations of 2 
adolescents with T1D and better glycemic control. 3 
In conclusion, in a predominantly normoalbuminuric cohort of young people with 4 
childhood-onset T1D, we demonstrated that enhanced cardiovascular reflexes 5 
predicted future increases in urine ACR. These suggest that detection of autonomic 6 
dysfunction early in the course of T1D may enable the identification of a 7 
subpopulation of patients at increased risk of microalbuminuria and diabetic 8 
nephropathy, and who, a priori, may benefit from earlier interventions.   9 
 10 
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Tables 1 
Table 1. Clinical and autonomic characteristics of study participants 2 
Study Parameters  
N 199 
Female (%) 47.2 
Age at diagnosis (years) 9.25 (5.94 – 11.80) 
Duration of diabetes at autonomic assessment (years) 5.17 ± 0.35 
Age at autonomic assessment (years) 14.16 (11.02 – 17.02) 
Duration of follow-up after autonomic assessment (years)  8.59 ± 3.39 
Mean HbA1c during entire follow-up (%) [mol/mol] 9.69 ± 1.38 [82.4 ± 15.1] 
Mean HbA1c after autonomic assessment (%) [mol/mol] 9.63 ± 1.42 [82.0 ± 15.5] 
Mean log10ACR during entire follow-up  0.023 ± 0.282 
Mean log10ACR after autonomic assessment  0.085 ± 0.347 
HR response to Valsalva Maneuver  1.76 ± 0.40 
HR response to deep breathing (bpm)  28.85 ± 8.19 
HR response to standing (30:15 ratio) 1.24 ± 0.20 
HR response to standing  1.38 ± 0.20 
Systolic BP response to standing (mmHg)  -0.43 ± 9.42 
Diastolic BP response to standing(mmHg)  3.06 ± 9.86 
Average values are given as mean ± SD if normally distributed or median (IQR) if not. 3 
ACR: albumin creatinine ratio, HR: heart rate, BP: blood pressure.4 
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Table 2. Linear mixed model: Effect of autonomic parameters and other 1 
covariates on change of longitudinal ACR (% change per year) 2 
Variable  Effect Size 95% CI p-value 
Female sex 0.85 -3.18; 5.05 0.68 
Duration of diabetes (years) -2.63 -8.14; 3.20 0.37 
Age at assessment (years) 0.12 -0.42; 0.67 0.66 
Average HbA1c (%) 3.91 2.36; 5.48 <0.001 
HR response to Valsalva 
Maneuver (Z score) 
2.16 0.12; 4.24 0.038 
HR response to standing (Z 
score) 
-2.40 -4.43; -0.33 0.023 
CI: confidence interval; HR: heart rate 3 
4 
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Figure Legends 1 
Figure 1. Longitudinal profile of urine albumin-creatinine ratio (ACR). Urine ACR 2 
increased with time in participants who developed micro- or macroalbuminuria (MA) 3 
(p=0.004), but decreased in participants who remained normoalbuminuric (no MA) 4 
(p<0.001).  5 
Figure 2. Effect of individual autonomic parameters on the rate of change of 6 
longitudinal ACR. Age at autonomic assessment, duration of diabetes, mean HbA1c 7 
during follow-up and sex were adjusted for. Effect sizes of the individual autonomic 8 
parameters were standardized to their SDs. HR: heart rate, BP: blood pressure. * 9 
refers to p<0.05. † refers to p=0.051.  10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
23 
 
Figure 1 1 
 2 
 3 
 4 
 5 
 6 
 7 
24 
 
Figure 2 1 
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